Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Finkel

Showing results (211-220 of 289) with videos related to

Pageof 29
Sort By:
Annals of Neurology|February 27, 2013
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophyKevin M Flanigan, Ermelinda Ceco, Kay-Marie Lamar, et al.
Journal of Neuromuscular Diseases|January 22, 2024
Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE RegistryLaurent Servais, John W Day, Darryl C De Vivo, et al.
Plos One|September 10, 2014
Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional studySean C Forbes, Rebecca J Willcocks, William T Triplett, et al.
Annals of Neurology|February 20, 2016
Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohortRebecca J Willcocks, William D Rooney, William T Triplett, et al.
Lancet (London, England)|March 13, 2022
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialCraig M McDonald, Eduardo Marbán, Suzanne Hendrix, et al.
BMJ Neurology Open|April 1, 2026
Peripheral frataxin levels govern long-term clinical progression in Friedreich ataxiaChristian Rummey, Ian A Blair, Clementina Mesaros, et al.
Muscle & Nerve|February 2, 2019
Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophyAnne M Connolly, Craig M Zaidman, Paul T Golumbek, et al.
Annals of Neurology|January 23, 2015
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45Andrew R Findlay, Nicolas Wein, Yuuki Kaminoh, et al.
Brain : a Journal of Neurology|June 25, 2024
TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestationsGage P Kosmanopoulos, Jack K Donohue, Maya Hoke, et al.
The New England Journal of Medicine|November 2, 2017
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular AtrophyRichard S Finkel, Eugenio Mercuri, Basil T Darras, et al.
Pageof 29

Showing results (211-220 of 289) with videos related to

Sort By:
Pageof 29
Annals of Neurology|February 27, 2013
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophyKevin M Flanigan, Ermelinda Ceco, Kay-Marie Lamar, et al.
Journal of Neuromuscular Diseases|January 22, 2024
Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE RegistryLaurent Servais, John W Day, Darryl C De Vivo, et al.
Plos One|September 10, 2014
Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional studySean C Forbes, Rebecca J Willcocks, William T Triplett, et al.
Annals of Neurology|February 20, 2016
Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohortRebecca J Willcocks, William D Rooney, William T Triplett, et al.
Lancet (London, England)|March 13, 2022
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialCraig M McDonald, Eduardo Marbán, Suzanne Hendrix, et al.
BMJ Neurology Open|April 1, 2026
Peripheral frataxin levels govern long-term clinical progression in Friedreich ataxiaChristian Rummey, Ian A Blair, Clementina Mesaros, et al.
Muscle & Nerve|February 2, 2019
Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophyAnne M Connolly, Craig M Zaidman, Paul T Golumbek, et al.
Annals of Neurology|January 23, 2015
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45Andrew R Findlay, Nicolas Wein, Yuuki Kaminoh, et al.
Brain : a Journal of Neurology|June 25, 2024
TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestationsGage P Kosmanopoulos, Jack K Donohue, Maya Hoke, et al.
The New England Journal of Medicine|November 2, 2017
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular AtrophyRichard S Finkel, Eugenio Mercuri, Basil T Darras, et al.
Pageof 29